Clinical Outcomes of Subsequent Therapies in Patients with Relapsed/Refractory Multiple Myeloma Following Talquetamab Treatment: Analyses from the Phase 1/2 MonumenTAL-1 Study

被引：10

作者：

Sanchez, Larysa ^{[1
]}

Schinke, Carolina ^{[2
]}

Krishnan, Amrita ^{[3
]}

Berdeja, Jesus G. ^{[4
]}

de Donk, Niels W. C. J. van ^{[5
]}

Mateos, Maria Victoria ^{[6
]}

Chari, Ajai ^{[7
]}

Parekh, Samir ^{[8
]}

Mouhieddine, Tarek H. ^{[9
]}

Jagannath, Sundar ^{[10
]}

Bahlis, Nizar J. ^{[11
]}

Touzeau, Cyrille ^{[12
]}

Oriol, Albert ^{[13
,14
]}

San-Miguel, Jesus ^{[15
]}

Otero, Paula Rodriguez ^{[16
]}

Minnema, Monique C. ^{[17
]}

Campagna, Michela ^{[18
]}

Masterson, Tara J. ^{[19
]}

Hilder, Brandi W. ^{[19
]}

Tolbert, Jaszianne ^{[19
]}

Renaud, Thomas ^{[20
]}

Gray, Kathleen ^{[21
]}

Smit, Damiette ^{[22
]}

Heuck, Christoph ^{[19
]}

Rasche, Leo ^{[23
]}

机构：

[1] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY USA

[2] Univ Arkansas Med Sci, Myeloma Ctr, Little Rock, AR USA

[3] City Hope Natl Med Ctr, Judy & Bernard Briskin Ctr Multiple Myeloma Res, Irvine, CA USA

[4] Sarah Cannon Res Inst, Nashville, TN USA

[5] Vrije Univ Amsterdam, Amsterdam Univ Med Ctr, Amsterdam, Netherlands

[6] Univ Hosp Salamanca IBSAL CIC CIBERONC, Salamanca, Spain

[7] Mt Sinai Sch Med, New York, NY USA

[8] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY USA

[9] Icahn Sch Med Mt Sinai, Dept Med Hematol & Med Oncol, Tisch Canc Inst, New York, NY USA

[10] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY USA

[11] Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB, Canada

[12] Ctr Hosp Univ Nantes, Nantes, France

[13] Hosp Germans Trias I Pujol, Inst Catala Oncol, Barcelona, Spain

[14] Hosp Germans Trias I Pujol, Inst Josep Carreras, Barcelona, Spain

[15] Clin Univ Navarra, Inst Invest Sanitaria Navarra, Ctr Invest Med Aplicada, Ctr Invest Biomed Red Canc CIBERONC, Pamplona, Spain

[16] Clin Univ Navarra, Pamplona, Spain

[17] Univ Med Ctr Utrecht, Utrecht, Netherlands

[18] Janssen Res & Dev, Madrid, Spain

[19] Janssen Res & Dev, Spring House, PA USA

[20] Janssen Res & Dev, Raritan, NJ USA

[21] Janssen Sci Affairs, Horsham, PA USA

[22] Janssen Biol Europe, Leiden, Netherlands

[23] Univ Hosp Wurzburg, Wurzburg, Germany

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-182330

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：7

共 50 条

[1] Mechanisms of Resistance and Relapse with Talquetamab in Patients with Relapsed/Refractory Multiple Myeloma from the Phase 1/2 MonumenTAL-1 Study
Vishwamitra, Deeksha
Skerget, Sheri
Cortes, Diana
Lau, Onsay
Davis, Cuc
Renaud, Thomas
Tolbert, Jaszianne
Hilder, Brandi W.
Masterson, Tara J.
Campagna, Michela
Heuck, Christoph
Chari, Ajai
van de Donk, Niels W. C. J.
Verona, Raluca
BLOOD, 2023, 142
[2] Plain language summary of the MonumenTAL-1 study of talquetamab in people with relapsed or refractory multiple myeloma
不详
FUTURE ONCOLOGY, 2023, 19 (27) : 1823 - 1840
[3] Prophylactic Tocilizumab to Mitigate Cytokine Release Syndrome in Patients Receiving Talquetamab for Relapsed/Refractory Multiple Myeloma: Results From the Phase 1/2 MonumenTAL-1 Study
Schinke, Carolina
Vij, Ravi
Jagannath, Sundar
Sanchez, Larysa
Pianko, Matthew
Jakubowiak, Andrzej
Masterson, Tara J.
Campagna, Michela
Zhang, Guoqiang
Gray, Kathleen
Renaud, Thomas
Lau, Bonnie W.
Morgan, Gareth
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S86 - S86
[4] Efficacy and Safety of Less Frequent/Lower Intensity Dosing of Talquetamab in Patients with Relapsed/Refractory Multiple Myeloma: Results from the Phase 1/2 MonumenTAL-1 Study
Chari, Ajai
Oriol, Albert
Krishnan, Amrita
Martinez Chamorro, Maria Del Carmen
Costa, Luciano
Mateos, Maria Victoria
Minnema, Monique C.
Campagna, Michela
Masterson, Tara J.
Hilder, Brandi W.
Tolbert, Jaszianne
Renaud, Thomas
Smit, M. Damiette
Ramanjulu, Swarna
Otero, Paula Rodriguez
BLOOD, 2023, 142
[5] Symptoms, Functioning, and Health-Related Quality of Life in Patients with Relapsed/Refractory Multiple Myeloma Treated with Talquetamab: Updated PatientReported Outcomes from the Phase 1/2 MonumenTAL-1 Study
Schinke, Carolina
Touzeau, Cyrille
Oriol, Albert
Mateos, Maria-Victoria
Stevens, Don A.
Rasche, Leo
Qin, Xiang
Kato, Kelly
Ming, Timothy
Katz, Eva G.
Gries, Katharine S.
Campagna, Michela
Masterson, Tara J.
Hilder, Brandi W.
Tolbert, Jaszianne
Renaud, Thomas
Heuck, Christoph
Moreau, Philippe
San-Miguel, Jesus
Rodriguez Otero, Paula
Chari, Ajai
BLOOD, 2023, 142
[6] Cytokine Release Syndrome in Patients Receiving Alternative Step-Up Doses of Talquetamab for Relapsed/Refractory Multiple Myeloma: Results from the Phase 1/2 MonumenTAL-1 Study
Morillo, Daniel
Chamorro, Carmen Martinez
Mateos Manteca, Maria-Victoria
Costa, Luciano
Minnema, Monique
Sanchez, Larysa
Hilder, Brandi
Singh, Indrajeet
Gong, Joy
Lau, Bonnie W.
Renaud, Thomas
Rodriguez-Otero, Paula
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S74 - S75
[7] Efficacy and Safety of Talquetamab, a GPRC5DxCD3 Bispecific Antibody, in Japanese Patients with Relapsed/Refractory Multiple Myeloma from the Phase 1/2 Monumental-1 Study
Ito, Shigeki
Kuroda, Yoshiaki
Sunami, Kazutaka
Matsue, Kosei
Imada, Kazunori
Tamura, Hideto
Takamoto, Mikihiro
Yamazaki, Hiroshi
Fujikawa, Ei
Pei, Lixia
Masterson, Tara J.
Campagna, Michela
Lau, Bonnie W.
Takamatsu, Yasushi
BLOOD, 2024, 144 : 7011 - 7012
[8] Long-Term Efficacy and Safety Results From the Phase 1/2 MonumenTAL-1 Study of Talquetamab, a GPRC5DxCD3 Bispecific Antibody, in Patients With Relapsed/Refractory Multiple Myeloma
Ye, Jing Christine
Schinke, Carolina
Touzeau, Cyrille
Minnema, Monique
van de Donk, Niels
Rodriguez-Otero, Paula
Mateos Manteca, Maria-Victoria
Rasche, Leo
Vishwamitra, Deeksha
Singh, Indrajeet
Qin, Xiang
Campagna, Michela
Hilder, Brandi
Tolbert, Jaszianne
Renaud, Thomas
Heuck, Christoph
Kane, Colleen
Chari, Ajai
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S99 - S99
[9] Updated Results of Talquetamab, a GPRC5DxCD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma with Prior Exposure to T-Cell Redirecting Therapies: Results of the Phase 1/2 MonumenTAL-1 Study
Jakubowiak, Andrzej J.
Anguille, Sebastien
Karlin, Lionel
Chari, Ajai
Schinke, Carolina
Rasche, Leo
San-Miguel, Jesus
Campagna, Michela
Hilder, Brandi W.
Masterson, Tara J.
Qin, Xiang
Renaud, Thomas
Tolbert, Jaszianne
Vishwamitra, Deeksha
Skerget, Sheri
Moreau, Philippe
BLOOD, 2023, 142
[10] Analysis of Infections and Parameters of Humoral Immunity in Patients (pts) With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With Talquetamab (tal) Monotherapy in MonumenTAL-1
Rodriguez-Otero, Paula
Schinke, Carolina
Chari, Ajai
Lipe, Brea
Lavi, Noa
Rasche, Leo
Vishwamitra, Deeksha
Skerget, Sheri
Verona, Raluca
Ma, Xuewen
Khedkar, Sheetal
Hilder, Brandi
Masterson, Tara
Campagna, Michela
Renaud, Thomas
Tolbert, Jaszianne
Heuck, Christoph
Smit, M. Damiette
van de Donk, Niels
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S480 - S480

← 1 2 3 4 5 →